ReviewExpert review of pharmacoeconomics & outcomes research2021

Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews.

Vakaramoko Diaby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.